BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 26792482)

  • 1. Incidence of toxic optic neuropathy with low-dose ethambutol.
    Yang HK; Park MJ; Lee JH; Lee CT; Park JS; Hwang JM
    Int J Tuberc Lung Dis; 2016 Feb; 20(2):261-4. PubMed ID: 26792482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re-Treatment With Ethambutol After Toxic Optic Neuropathy.
    Bouffard MA; Nathavitharana RR; Yassa DS; Torun N
    J Neuroophthalmol; 2017 Mar; 37(1):40-42. PubMed ID: 27636749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and clinical features of ethambutol-induced optic neuropathy in Korea.
    Lee EJ; Kim SJ; Choung HK; Kim JH; Yu YS
    J Neuroophthalmol; 2008 Dec; 28(4):269-77. PubMed ID: 19145123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethambutol ocular toxicity in treatment regimens for Mycobacterium avium complex lung disease.
    Griffith DE; Brown-Elliott BA; Shepherd S; McLarty J; Griffith L; Wallace RJ
    Am J Respir Crit Care Med; 2005 Jul; 172(2):250-3. PubMed ID: 15860751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural-functional dissociation in presumed ethambutol optic neuropathy.
    Masvidal D; Parrish RK; Lam BL
    J Neuroophthalmol; 2010 Dec; 30(4):305-10. PubMed ID: 20592624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethambutol optic neuropathy associated with enhancement at the optic chiasm.
    Lu PG; Kung NH; Van Stavern GP
    Can J Ophthalmol; 2017 Oct; 52(5):e178-e181. PubMed ID: 28985827
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment Outcomes after Discontinuation of Ethambutol due to Adverse Events in
    Kwon YS; Kwon BS; Kim OH; Park YE; Shim TS; Chong YP; Jo KW
    J Korean Med Sci; 2020 Mar; 35(9):e59. PubMed ID: 32141249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethambutol/Linezolid Toxic Optic Neuropathy.
    Libershteyn Y
    Optom Vis Sci; 2016 Feb; 93(2):211-7. PubMed ID: 26636399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and prognostic factor of ethambutol-related optic neuropathy: 10-year experience in southern Taiwan.
    Chen SC; Lin MC; Sheu SJ
    Kaohsiung J Med Sci; 2015 Jul; 31(7):358-62. PubMed ID: 26162816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethambutol-induced optic neuropathy: a nationwide population-based study from Taiwan.
    Chen HY; Lai SW; Muo CH; Chen PC; Wang IJ
    Br J Ophthalmol; 2012 Nov; 96(11):1368-71. PubMed ID: 22960095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular ethambutol toxicity.
    Melamud A; Kosmorsky GS; Lee MS
    Mayo Clin Proc; 2003 Nov; 78(11):1409-11. PubMed ID: 14601701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual Recovery Time in Patients with Ethambutol-induced Toxic Optic Neuropathy.
    An HR; Lee BJ; Moon Y
    Korean J Ophthalmol; 2024 Apr; 38(2):91-97. PubMed ID: 38351490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pupillary light reflex in ethambutol-induced optic neuropathy.
    Yoo YJ; Hwang JM; Yang HK
    Sci Rep; 2020 Dec; 10(1):21601. PubMed ID: 33303779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased retinal nerve fibre layer thickness detected by optical coherence tomography in patients with ethambutol-induced optic neuropathy.
    Chai SJ; Foroozan R
    Br J Ophthalmol; 2007 Jul; 91(7):895-7. PubMed ID: 17215265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethambutol-induced optic neuropathy in renal disorder: a clinico-electrophysiological study.
    Kanaujia V; Jain VK; Sharma K; Agarwal R; Mishra P; Sharma RK
    Can J Ophthalmol; 2019 Jun; 54(3):301-305. PubMed ID: 31109468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethambutol-related impaired visual function in childrens less than 5 years of age treated for a mycobacterial infection: diagnosis and evolution.
    Levy M; Rigaudière F; de Lauzanne A; Koehl B; Melki I; Lorrot M; Faye A
    Pediatr Infect Dis J; 2015 Apr; 34(4):346-50. PubMed ID: 25764095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethambutol and optic neuropathy.
    Chuenkongkaew W; Samsen P; Thanasombatsakul N
    J Med Assoc Thai; 2003 Jul; 86(7):622-5. PubMed ID: 12948256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower dose of ethambutol may reduce ocular toxicity without radiological deterioration for Mycobacterium avium complex pulmonary disease.
    Ando T; Kage H; Matsumoto Y; Zokumasu K; Nagase T
    Respir Investig; 2021 Nov; 59(6):777-782. PubMed ID: 34389250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic drug monitoring in the treatment of Mycobacterium avium complex lung disease.
    Koh WJ; Jeong BH; Jeon K; Lee SY; Shin SJ
    Am J Respir Crit Care Med; 2012 Oct; 186(8):797-802. PubMed ID: 22878282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of copper on ethambutol's antimicrobial action and implications for ethambutol-induced optic neuropathy.
    Kozak SF; Inderlied CB; Hsu HY; Heller KB; Sadun AA
    Diagn Microbiol Infect Dis; 1998 Feb; 30(2):83-7. PubMed ID: 9554173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.